Neuroendocrine tumors (NETs) present numerous complex clinical problems. Due to their relatively rare occurrence, research and patient care guidelines since the 1990s have been lacking. As a result, the European Neuroendocrine Tumor Society was founded in 2004 and the society members, currently numbering nearly 1,400, bring a variety of expertise from such fields as oncology, pathology, radiology, nuclear medicine, endocrinology, surgery and gastroenterology to ENETS.


 ENETS goals include

  • improve the diagnosis and therapy of patients with neuroendocrine tumors in an international, interdisciplinary and scientific context
  • coordinate research at European hospitals and health research institutes, with emphasis on basic and clinical research for the diagnosis and treatment of NETs

  • further develop standards for the accreditations of ENETS Centers of Excellence

  • offer education and training for physicians and scientists at annual scientific and educational meetings

  • focus on writing and updating NET guidelines for all aspects of NET care including treatment and standards of care and subsequently publicising in medical and scientific journals

  • foster the exchange of forums for young investigators

  • support collaborative scientific projects of excellence

  • communicate with and inform patient advocates and patient self-help groups

  • cooperate with the pharmaceutical industry for the development of new diagnostic, therapeutic and information technologies

  • further endorse the ENETS Registry and Centers of Excellence throughout Europe